Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Recommendation is based on pivotal data from the phase III POLARIX study
Subscribe To Our Newsletter & Stay Updated